Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 310, pseudogene (RN7SL310P) is a human pseudogene derived from sequences similar to the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP)[1][5]. The majority of 7SL-like sequences in the human genome are pseudogenes resulting from the integration of 7SL RNA back into the DNA, often truncated and non-functional[3][5]. RN7SL310P is classified as a processed pseudogene and does not encode a functional product[1][3]. There is no evidence that RN7SL310P has a direct biological function, disease association, or acts as a therapeutic target. The functional 7SL RNA gene is associated with SRP and involved in protein targeting, but this pseudogene itself is not expressed or functionally relevant in therapeutic contexts[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 310, pseudogene (RN7SL310P).